Atlas Trials

Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations

Clinical trial NCT03475589 · UNKNOWN

Trial details

NCT number
NCT03475589
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Stage IV Cancer
Start date
2018-02-26
Primary completion
2020-12-01
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.